Zobrazeno 1 - 10
of 2 273
pro vyhledávání: '"Ejlertsen"'
Publikováno v:
Clinical Epidemiology, Vol Volume 8, Pp 445-449 (2016)
Peer Christiansen,1 Bent Ejlertsen,2,3 Maj-Britt Jensen,3 Henning Mouridsen3 1Department of Surgery P, Breast Surgery Unit, Aarhus University Hospital/Randers Regional Hospital, Aarhus C, 2Department of Oncology, Rigshospitalet, Copenhagen University
Externí odkaz:
https://doaj.org/article/2a8588cef5b549b4836fd5a6b08d6b26
Autor:
Kirsten M. Woolpert, Julie A. Schmidt, Thomas P. Ahern, Cathrine F. Hjorth, Dóra K. Farkas, Bent Ejlertsen, Lindsay J. Collin, Timothy L. Lash, Deirdre P. Cronin-Fenton
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Introduction Patients with hormone receptor positive breast cancer are recommended at least five years of adjuvant endocrine therapy, but adherence to this treatment is often suboptimal. We investigated longitudinal trends in adjuvant endocr
Externí odkaz:
https://doaj.org/article/091fb63dec7f4ac986c7af6f5c78c063
Autor:
Tobias Berg, Maj-Britt Jensen, Maria Rossing, Christian T. Axelsen, Iben Kümler, Lise Søndergaard, Marianne Vogsen, Ann S. Knoop, Bent Ejlertsen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: Primary metastatic breast cancer (pMBC) accounts for 5–10% of annual breast cancers with a median survival of 3–4 years, varying among subtypes. In Denmark, the incidence of breast cancer increased until 2010, followed by a stabilisat
Externí odkaz:
https://doaj.org/article/22476371f20f4d8e9fc8ba7ab74c6cb6
Autor:
Kåre Nielsen, Michael Sode, Maj-Britt Jensen, Tobias Berg, Ann Knoop, Bent Ejlertsen, Anne-Vibeke Lænkholm
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-15 (2023)
Abstract Background Considering the recent advancements in the treatment of breast cancer with low expression of human epidermal growth factor receptor 2 (HER2), we aimed to examine inter-laboratory variability in the assessment of HER2-low breast ca
Externí odkaz:
https://doaj.org/article/583bda67c17f4c7397476b126b81c79d
Autor:
M.-B. Jensen, C. B. Pedersen, M.-A. Misiakou, M.-L. M. Talman, L. Gibson, U. B. Tange, H. Kledal, I. Vejborg, N. Kroman, F. C. Nielsen, B. Ejlertsen, M. Rossing
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-8 (2023)
Abstract Estrogen receptor (ER) and human epidermal growth factor 2 (HER2) expression guide the use of neoadjuvant chemotherapy (NACT) in patients with early breast cancer. We evaluate the independent predictive value of adding a multigene profile (C
Externí odkaz:
https://doaj.org/article/ff3caa07d0ed41afa27aecb8c872a1bd
Autor:
Taylor, Carolyn, Dodwell, David, McGale, Paul, Hills, Robert K, Berry, Richard, Bradley, Rosie, Braybrooke, Jeremy, Clarke, Mike, Gray, Richard, Holt, Francesca, Liu, Zulian, Pan, Hongchao, Peto, Richard, Straiton, Ewan, Coles, Charlotte, Duane, Fran, Hennequin, Christophe, Jones, Glenn, Kühn, Thorsten, Oliveros, Sileida, Overgaard, Jens, Pritchard, Kathy I, Suh, Chang-Ok, Beake, Graham, Boddington, Clare, Davies, Christina, Davies, Lucy, Evans, Vaughan, Gay, Jo, Gettins, Lucy, Godwin, Jon, James, Sam, Kerr, Amanda, Liu, Hui, MacKinnon, Elizabeth, Mannu, Gurdeep, McHugh, Theresa, Morris, Philip, Nakahara, Mariko, Read, Simon, Taylor, Hannah, Ferguson, John, Scheurlen, Hans, Zurrida, Stefano, Galimberti, Viviana, Ingle, James, Valagussa, Pinuccia, Veronesi, Umberto, Anderson, Stewart, Tang, Gong, Fisher, Bernard, Fossa, Sophie, Valborg Reinertsen, Kristin, Host, Herman, Muss, Hyman, Holli, Kaija, Albain, Kathy, Arriagada, Rodrigo, Bartlett, John, Bergsten-Nordström, Elizabeth, Bliss, Judith, Brain, Etienne, Carey, Lisa, Coleman, Robert, Cuzick, Jack, Davidson, Nancy, Del Mastro, Lucia, Di Leo, Angelo, Dignam, James, Dowsett, Mitch, Ejlertsen, Bent, Francis, Prue, García-Sáenz, José Angel, Gelber, Rich, Gnant, Michael, Goetz, Matthew, Goodwin, Pam, Halpin-Murphy, Pat, Hayes, Dan, Hill, Catherine, Jagsi, Reshma, Janni, Wolfgang, Loibl, Sibylle, Mamounas, Eleftherios, Martín, Miguel, McIntosh, Stuart, Mukai, Hirofumi, Nekljudova, Valentina, Norton, Larry, Ohashi, Yasuo, Piccart, Martine, Pierce, Lori, Raina, Vinod, Rea, Daniel, Regan, Meredith, Robertson, John, Rutgers, Emiel, Salgado, Roberto, Slamon, Dennis, Spanic, Tanja, Sparano, Joseph, Steger, Guenther, Toi, Masakazu, Tutt, Andrew, Viale, Giuseppe, Wang, Xiang, Wilcken, Nicholas, Wolmark, Norman, Yu, Ke-Da, Cameron, David, Bergh, Jonas, Swain, Sandra, Whelan, Tim, Poortmans, Philip
Publikováno v:
In The Lancet 25 November-1 December 2023 402(10416):1991-2003
Publikováno v:
BMC Research Notes, Vol 5, Iss 1, p 609 (2012)
Abstract Background Clostridium difficile ribotype 027 has become increasingly prevalent in European countries. The clinical picture varies from self-limiting diarrhea to pseudomembranous colitis with toxic megacolon and ultimately death. Use of anti
Externí odkaz:
https://doaj.org/article/646a38008c78460b8fb083c9d53e808f
Autor:
Skarphedinsson Sigurdur, Ejlertsen Tove, Bangsborg Jette M, Dessau Ram B, Schønheyder Henrik C
Publikováno v:
BMC Infectious Diseases, Vol 10, Iss 1, p 317 (2010)
Abstract Background Serological testing for Lyme borreliosis (LB) is frequently requested by general practitioners for patients with a wide variety of symptoms. Methods A survey was performed in order to characterize test utilization and clinical fea
Externí odkaz:
https://doaj.org/article/12f552087015409881908250ba2d35fe
Autor:
Lykkesfeldt Anne E, Henriksen Katrine L, Rasmussen Birgitte B, Sasano Hironobu, Evans Dean B, Møller Susanne, Ejlertsen Bent, Mouridsen Henning T
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 185 (2009)
Abstract Background New, third-generation aromatase inhibitors (AIs) have proven comparable or superior to the anti-estrogen tamoxifen for treatment of estrogen receptor (ER) and/or progesterone receptor (PR) positive breast cancer. AIs suppress tota
Externí odkaz:
https://doaj.org/article/85e890b48a9543edb5e939ba8947e77c
Autor:
Eiberg Hans, Filtenborg-Barnkob Bettina, Albrechtsen Anders, Jønson Lars, Bisgaard Marie, Hansen Thomas, Ejlertsen Bent, Nielsen Finn C
Publikováno v:
BMC Medical Genetics, Vol 9, Iss 1, p 58 (2008)
Abstract Background BRCA2 germ-line mutations predispose to breast and ovarian cancer. Mutations are widespread and unclassified splice variants are frequently encountered. We describe the parental origin and functional characterization of a novel de
Externí odkaz:
https://doaj.org/article/5533b662e6c44e56a7566437f22c6f84